• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

HAE [ Haemonetics Corp ]
Last Trade 87.33 Date 9/30/2020
Change % 0.55 % Price Change 0.47
Open 86.8 52 Week High 130.75
High 88.1 52 Week Low 63.41
Low 85.61 Type stock
Volume 160330 Average Volume 432692
Prev Close 86.86 Stock Exchange NYSE
Bid 87.18 Ask 87.41
Bid Size 2 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share Book Value Yield
Buy Back Yield CAPE Ratio
Cash Return Cash Flow per Share
Cash Flow Yield Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue EV / Total Asset
Expected Dividend Growth Rate Free Cash Flow per Share
Free Caash Flow Ratio Free Cash Flow Yield
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio
PB Ratio PB Ratio 10 Year Growth
PB Ratio 3 Year Growth Cash Ratio 3 Year Average
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average PE Ratio 10 Year Growth
PE Ratio 10 Year High PE Ratio 10 Year Low
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg
PE Ratio 5 Year Avg PE Ratio 5 Year High
PE Ratio 5 Year Low Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg Price Change 1 Month
Price to Cash Ratio Price / EBITDA
Price to Sales Ratio Price to Sales Ratio 10 Year Growth
Price to Sales Ratio 3 Year Avg Price to Sales Ratio 5 Year Avg
Sale per Share Sales Yield
Sustainable Growth Rate Tangible Book Value per Share
Tangible Book Value per Share 3 year Avg Tangible Book Value per Share 5 year Avg
Total Asset per Share Total Yield
Working Capital per Share Working Capital per Share 3 Year Avg
Working Capital per Share 5 Year Avg Beta
Company Profile

Haemonetics Corporation provides blood management solutions primarily in the United States, Europe, and Asia. The company?s donor products and services include plasma systems that automate the collection of plasma from donors; blood bank systems comprising MCS brand system, which automates the collection of platelets and other blood components from volunteer donors, and ACP brand systems that automate the process used to freeze, thaw, and wash red blood cells, as well as manufacture sterile intravenous solutions; red cell systems, which automates the collection of red cells from volunteer donors; and services and programs related to blood supply chain, such as LEAN and Six Sigma consulting, as well as InSight, a program application supporting blood center resource allocation and utilization. Its patient products and services comprise blood salvage systems that allow for the recovery, segregation, and washing of red cells from blood lost by a patient during or after surgery; SmartSuction product, which clears blood and debris from the surgical field; TEG Thrombelastograph Hemostasis Analyzer system, a diagnostic tool for surgeons; and blood management consulting. Haemonetics Corporation also provides information technology platforms and technical support for blood drive management, operations of blood and plasma collection centers, and management of back office functions and distribution at plasma fractionation facilities; business solutions to support process excellence, donor recruitment, business design, and blood management efforts; and hospital blood management assessment tools to hospitals. The company also offers equipment repair services, training programs, and spare part sales. It markets its products through direct sales force, independent distributors, and agents. Haemonetics Corporation was founded in 1971 and is based in Braintree, Massachusetts.